SCHEMBL3273759

SCHEMBL3273759

BrCc1ccccc1-c1cccnc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 4/20 0.59
KCNH2 Q12809 2/20 0.53
CYP2A6 P11509 6/20 0.50
ALDH1A1 P00352 3/20 0.50
CYP3A4 P08684 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP11B1 P15538 3/20 0.47
CYP11B2 P19099 2/20 0.47
ADRA2C P18825 1/20 0.46
PTGS2 P35354 1/20 0.45
MKNK1 Q9BUB5 1/20 0.44
MKNK2 Q9HBH9 1/20 0.44
TP53 P04637 2/20 0.44
NPC1 O15118 1/20 0.44
GAA P10253 1/20 0.44
RAB9A P51151 1/20 0.44
MAPT P10636 2/20 0.44
HTT P42858 2/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28224986 0.86 KCNA5 (0.47) KCNA5KCNH2CYP2A6ALDH1A1CYP3A4
SCHEMBL477395 0.83 KCNA5 (0.61) KCNA5KCNH2CYP2A6ALDH1A1CYP3A4
SCHEMBL9285273 0.81 KCNA5 (0.59) KCNA5KCNH2CYP2A6ALDH1A1CYP3A4
SCHEMBL21480329 0.81 KCNA5 (0.59) KCNA5KCNH2CYP2A6ALDH1A1CYP3A4
SCHEMBL3288789 0.81 DPP4 (0.62) KCNA5KCNH2CYP2A6ALDH1A1CYP3A4
SCHEMBL1130345 0.81 KCNA5 (0.59) KCNA5KCNH2CYP2A6ALDH1A1CYP3A4
SCHEMBL27383308 0.81 ATM (0.45) KCNA5KCNH2CYP2A6ALDH1A1CYP3A4
SCHEMBL5018831 0.81 KCNA5 (0.68) KCNA5KCNH2CYP2A6ALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL2456280 0.80 DPP4 (0.60) KCNA5KCNH2CYP2A6ALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL14856550 0.80 KCNA5 (0.58) KCNA5KCNH2CYP2A6ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399674-B2 Quinolines HOFFMAN-LA ROCHE INC. (US) 2013-03-19 US disclosed
US-20120136018-A1 QUINOLINES KOLCZEWSKI SABINE (DE) 2012-05-31 US disclosed
EP-2195296-A1 QUINOLINE DERIVATIVES AS 5HT5A RECEPTOR ANTAGONISTS F. Hoffmann-Roche AG (CH) 2010-06-16 EP disclosed
US-20090088451-A1 QUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2009-04-02 US disclosed
WO-2009040290-A1 QUINOLINE DERIVATIVES AS 5HT5A RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088451-A1 QUINOLINES HTR5A, HTR1A, HTR1E KCNA5 216/4885KCNH2 524/4885CYP2A6 471/4885
US-20120136018-A1 QUINOLINES HTR5A, HTR1A, HTR1E KCNA5 216/4885KCNH2 524/4885CYP2A6 471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.